Stents Market Size, Share, and Trends 2024 to 2034

Stents Market Size and Forecast 2024 to 2034

The global stents market size is exhibited at USD 13.64 billion in 2024 and is predicted to surpass around USD 25.25 billion by 2034, growing at a CAGR of 6.35% from 2024 to 2034.

Stents Market Key Takeaways

• By product, the coronary stents segment accounted the biggest market share in 2023.
• By material, the metallic biomaterial segment has dominated the market.
• The metallic materials segment growth of the polymeric bio-materials segment is also expected in the coming years.
• By end user, the hospital segment has emerged as the largest segment.
• By geography, the North America region has emerged as the largest market.

U.S. Stents Market Size and Growth 2024 to 2034

The U.S. stents market size is estimated at USD 4.20 billion in 2024 and is expected to be worth around USD 7.92 billion by 2034, rising at a CAGR of 6.53% from 2024 to 2034.

On the basis of geography, the region of North America has emerged as the largest market for stents due to the huge number of patients that reside in this particular region. A huge population belonging to the region of North America falls under the category of the geriatric age group. This results in sedentary lifestyle practices which emerge as a major reason for the increasing number of patients suffering with cardiovascular diseases. As the healing power of the people belonging to the geriatric population is weak, the demand for minimally invasive surgical procedures is increasing rapidly. This is in turn boosting the market for stents as they do not require wide incisions. As a result of modern lifestyle practices and sedentary habits, the cholesterol level of people is rising rapidly. This results in two severe blockages in the lumen of the heart which requires surgical management. The modern facilities that are provided to the people through the hospitals have also boosted the market in this particular region.

The region of Europe has also proved to be a rising market for stents as a result of the advanced healthcare services that are provided to the people by the government. The people belonging to the region of Europe make use of modern healthcare services and hence demand advanced surgical options with the utilization of modern equipment.

Market Overview

Stents are made of plastic or sometimes metal in the form of tiny tubes that are set up into the narrow lumen of the vessel. Various disorders related to the cardiovascular system require the utilization of stents for the correction of the flow of blood through the anatomic vessels and ducts. Various cardiac diseases such as peripheral artery disease, coronary heart disease, and thrombosis of the deep vein require the utilization of stents during the surgical management of the condition. 

Increasing demand for minimally invasive surgical procedures for the management of severe diseases is expected to boost the market for instance to a great extent. The adoption of modern technology in the field of medicine has emerged as a major opportunity for the growth of the stents market during the forecast period. A huge number of people all over the world are suffering from cardiovascular diseases and other related disorders of the urinary tract which require the utilization of stents. 

Stents Market Growth Factors

As a result of unhealthy lifestyle practices and sedentary habits, the number of patients suffering with cardiovascular disorders has increased gradually. Most of the patients suffering with diseases related to the cardiovascular system belong to the geriatric population. As a result of the lack of movement and exercise among the people belonging to the geriatric population, they are prone to attract cardiovascular disorders. Awareness among the population regarding the various healthcare options and facilities is increasing gradually. This has resulted in an increasing demand for minimally invasive surgical procedures. The utilization of minimally invasive surgical procedures proved to be extremely beneficial for people belonging to the geriatric age group. The wound healing capabilities of the surgical procedures that are conducted with minimally invasive methods are higher as compared to the other traditional methods. The adoption of modern technology in the healthcare system has also boosted the market for stents to a great extent. The outbreak of the pandemic had a positive impact on the growth of the market because of the huge number of patients who were suffering with cardiovascular disorders. A huge number of patients who were affected during the course of the pandemic were seen to be suffering with cardiovascular disorders. The utilization of stents was seen to be increasing rapidly for the various surgical procedures that were carried out on the people.

• The increasing number of people belonging to the geriatric population.
• Unhealthy modern lifestyle practices and sedentary habits.
• Increasing demand for procedures with minimally invasive methods.
• The increasing number of patients suffering with chronic diseases.

Market Scope

Market Dynamics

Key Market Drivers

• Advanced technology - The increasing demand for advanced technology in the field of medical science and healthcare has boosted the demand for stents in the market. The huge number of patients that belonged to the geriatric age group proved to be a driving force for the growth of the stent market. The higher disposable income that is available to the people has also enabled them to opt for advanced technologies and equipment that provide better results after the surgical procedure has been conducted. The utilization of advanced technologies has enabled potential consumers to have confidence in surgical procedures and techniques. The recent advancements that have taken place after the outbreak of the pandemic have helped to boost the market for stents.
• Increasing demand for surgical procedures - a gradual increase has been observed and the demand for advanced surgical procedures that make use of minimally invasive surgical methods. The modern equipment and devices that are utilized for conducting various surgical procedures related to the cardiovascular system have boosted the market for stents. A huge number of patients belonging to the geriatric population prefer to opt for surgical procedures as they do not have much time to wait for the action of the medicines on the body. The patient is suffering with severe blockages due to high cholesterol levels requiring surgical procedures which emerges as a major opportunity for the growth of the market during the forecast period. A huge number of people all over the world are suffering with severe cardiovascular diseases which emerges as a great opportunity for the growth of the market in the long run.

Key Market Opportunities

• Unhealthy lifestyle - As a result of modern lifestyle practices and sedentary habits the health of people has severely deteriorated. The number of patients suffering with cardiovascular disorders has increased rapidly over period of time. Patients suffering with major blockages require the utilization of advanced stents which help to boost the market to a great extent. A stressful work schedule and busy lifestyle have majorly impacted the cardiac health of the people which in turn emerges as a major opportunity for the growth of the stent market.
• Non-invasive procedures - The increasing demand for minimally invasive surgical procedures and management has boosted the demand for advanced stents. The utilization of minimally invasive surgical procedures proves to be beneficial for the healing process but usually requires a very long period of time. The non-invasive surgical procedures proved to be beneficial for patients who are suffering with diabetes as the healing process is faster. The increasing demand for modern technologies in the healthcare sector all over the world has also proved to be a great opportunity for the growth of the stents market.

Key Market Challenges

• Unfavorable government regulations - The various rules and regulations that are related to the development of modern technologies have hindered the growth of the stent market to a great extent. The unfavorable government regulations and guidelines prove to be an obstacle for the growth of the market in the long run. These obstacles have been experienced in the way of insurance coverage and taxes that make it difficult for the common people to opt for modern technologies. 

Product Insights

Based on product, the coronary stent segment accounted highest market share in 2022 as the cases of businesses associated with the heart have increased in recent years period the availability of advanced technology will also boost the market growth in the coming years. 

Apart from the growth of the coronary stents segment the peripheral stents segment is also expected to show significant growth during the coming years. An increase in the cases of disease of the peripheral artery will also play a significant role in the growth of the market. The failure of various organs in the human body has created more demand for implants of those organs due to which the need for the stains related to those implants have also increased in recent years and they shall also help in the growth of the market during the forecast period. It will show significant growth in many developed as well as developing economies of the world due to the availability of surgical procedures that make use of advanced technologies. 

Material Insights

The metallic segment has dominated the market in 2022 and most of the manufacturers in this industry are increasing their focus on the production of the stents used for cardiovascular diseases. The use of these metallic stents will increase as the cases of endoscopy and fluoroscopy have increased.

Apart from the growth of the metallic materials segment, the growth of the polymeric bio-materials segment is also expected in the coming years. The demand for polymeric stents has increased due to the increasing cases of cardiovascular diseases as the approvals sought from the government for this type of stent have also grown and the market is expected to grow well.

End User Insights

based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides multiple facilities to the patients as well as the medical staff and hence most people opt for the hospital sector for carrying out these surgical procedures. It is extremely essential to monitor the other vital parameters of the patient during the procedure, which is possible only within a hospital setup. Ambulatory surgical center segments will also show significant growth. As a result of the availability of multiple facilities within the hospitals, there shall be significant growth in these treatments in the hospitals.

Latest Announcements by Industry Leaders

MD, Shabana Shahanavaz, director of the Cardiac Catheterization Laboratory at Cincinnati Children's, confirmed his remark about the FDA approval of Renata Minima stent in August 2024. In the course of her 15 years as an interventional cardiologist, Shahanavaz has hailed this technology, which allows dilatation to a normal adult size once implanted in an infant, as groundbreaking. This is the very first stent that is meant to be used for babies only.

Stents Market Companies

• Medtronic plc
• Cook Medical
• B. Braun Melsungen AG
• Terumo Corporation
• Vascular Concepts
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina 
• Biosensors International Group Limited
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG 

Recent Developments:

• In December 2024, Fluid Biomed Inc. wrapped up a $27 million Series A equity financing, co-led by Amplitude Ventures and one of its major strategic partners, and new investors including IAG Capital Partners, LifeArc Ventures, ShangBay Capital, and METIS Innovative.
• In May 2024, A new line of production in India  launched by Abbott-the XIENCE Sierra-named everolimus-eluting coronary stent system after the approval from the Central. Drugs Standard Control Organization in February. It is the latest generation in everolimus-eluting coronary stent systems, XIENCE family.

Segments Covered in the Report

By Product

• Peripheral stents
• Coronary stents
• Stent related implants

By Material

• Metallic biomaterial
• Polymer biomaterial
• Natural Biomaterial

By End User

• Hospitals
• Ambulatory surgical centers
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)